Tradestie Institutional Equity Comparison Engine
DCTH vs SIBN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DCTH Overall Edge
DCTH Captures Institutional Edge (3โ1 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical while SIBN counters with relative strength in Options & Structure. Fundamentally, DCTH trades at N/M Forward P/E with 5.2% operating margin (+70.7% YoY revenue) versus SIBN at N/M Forward P/E and -7.6% operating margin (+14.5% YoY). In options structure, DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro) against SIBN sits in BREAKOUT (14th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
DCTH
DCTH N/M vs SIBN N/M Fwd P/E
Growth & Margin Winner
DCTH
Op Margin 5.2% vs -7.6% ยท YoY +70.7% vs +14.5%
Momentum & Technical Winner
DCTH
1Y +128.6% vs +34.9% ยท 52W Pos 80% vs 82%
Options & Structure Winner
SIBN
BREAKOUT (43rd %ile IV) vs BREAKOUT (14th %ile IV)
DCTH
NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap
$743.8M
1M Return
+39.77%
1Y Return
+128.57%
Forward P/E
N/M
Unified AI Score
35.9 / 100
SELL
Tech 50.0
Fund 38.0
Flow 60.0
Mom 54.0
SIBN
NASDAQ
SI-BONE, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$23.29
-0.64% 1D
Market Cap
$1.1B
1M Return
+18.34%
1Y Return
+34.94%
Forward P/E
N/M
Unified AI Score
38.3 / 100
SELL
Tech 8.0
Fund 30.0
Flow 71.0
Mom 31.4
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DCTH +128.57%
SIBN +34.94%
Spread: +93.63 pp (DCTH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DCTH Revenue | SIBN Revenue | DCTH Op. Margin | SIBN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $60M | N/A | -21.6% | SIBN |
| FY2019 | N/A | $70M | N/A | -53.5% | SIBN |
| FY2020 | N/A | $70M | N/A | -52.6% | SIBN |
| FY2021 | $0M | $90M | -690.0% | -57.3% | SIBN |
| FY2022 | $0M | $110M | -1245.1% | -56.0% | SIBN |
| FY2023 | $0M | $140M | -1849.0% | -33.8% | SIBN |
| FY2024 | $40M | $170M | -33.4% | -21.1% | SIBN |
| FY2025 | $90M | $200M | 0.8% | -11.1% | DCTH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DCTH | SIBN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $743.8M | $1.1B | Larger Scale | SIBN |
| Trailing P/E Ratio Valuation | 133.6x | N/M | Lower Multiple | DCTH |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +70.7% | +14.5% | Higher Growth | DCTH |
| Operating Margin (TTM) Profitability | 5.2% | -7.6% | Higher Margin | DCTH |
| Net Profit Margin Profitability | 6.0% | -6.2% | Higher Margin | DCTH |
| Return on Equity (ROE) Capital Efficiency | 5.4% | -7.7% | Higher ROE | DCTH |
| 52-Week Range Position Momentum | 80% ($8โ$23) | 82% ($11โ$26) | Stronger Trend | SIBN |
| Beta / 30D Volatility Risk Regime | 1.63ฮฒ ยท 131% Vol | 0.74ฮฒ ยท 77% Vol | Lower Realized Risk | SIBN |
| Unified Institutional Score Composite Signal | 35.9 / 100 (SELL) | 38.3 / 100 (SELL) | Higher Composite | SIBN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DCTH vs SIBN Buy Guide
DCTH
BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
43rd %ile
IV Regime
Balanced (25thโ60th %ile)
SIBN
BREAKOUT
74d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
14th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DCTH nor SIBN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.